| Why carry out this study? |
| Real-time continuous glucose monitoring (rt-CGM) could potentially improve glucose control in patients with type 2 diabetes (T2D). |
| The present analysis aimed to conduct a cost-effectiveness analysis of rt-CGM in patients with T2D on insulin therapy compared with self-monitoring of blood glucose (SMBG) in a UK setting. |
| What was learned from the study? |
| Rt-CGM was associated with increased quality-adjusted life expectancy and increased mean total lifetime costs versus SMBG in people with T2D on insulin therapy. |
| In the UK, in patients with T2D on insulin therapy, rt-CGM is highly likely to be cost effective compared with SMBG. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.